1. Home
  2. SSYS vs KROS Comparison

SSYS vs KROS Comparison

Compare SSYS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratasys Ltd. (Israel)

SSYS

Stratasys Ltd. (Israel)

N/A

Current Price

$9.35

Market Cap

806.5M

Sector

Technology

ML Signal

N/A

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$21.22

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSYS
KROS
Founded
1989
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
806.5M
655.9M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SSYS
KROS
Price
$9.35
$21.22
Analyst Decision
Strong Buy
Buy
Analyst Count
2
12
Target Price
$12.75
$22.20
AVG Volume (30 Days)
767.5K
1.0M
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$561,461,000.00
$246,718,000.00
Revenue This Year
N/A
$6,876.34
Revenue Next Year
$2.76
N/A
P/E Ratio
N/A
$12.87
Revenue Growth
N/A
37798.31
52 Week Low
$8.12
$9.12
52 Week High
$12.88
$22.55

Technical Indicators

Market Signals
Indicator
SSYS
KROS
Relative Strength Index (RSI) 52.80 64.42
Support Level $8.91 $19.76
Resistance Level $9.40 $21.75
Average True Range (ATR) 0.31 1.10
MACD 0.08 -0.11
Stochastic Oscillator 54.62 76.69

Price Performance

Historical Comparison
SSYS
KROS

About SSYS Stratasys Ltd. (Israel)

Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: